We’re excited to announce that Digistain® has partnered Deloitte to drive adoption across Europe! This collaboration marks a significant step toward making breast cancer risk
We’re thrilled to announce that Digistain® is now available to over 60% of UK private patients, with reimbursement available though Bupa, WPA Health Insurance &
We’re proud to share that our landmark clinical validation study, published earlier this year in Breast Cancer Research and Treatment, has been recognised as one
We are thrilled to share the announcement today that Digistain® are 1 of 4 FINALISTS for the 2024 Nature Spin-off Prize Over 150 innovative technologies
We are delighted to be in Abu Dhabi this week attending Abu Dhabi Global Healthcare Week with a UK delegation of NHS Organisations and digital
Wonderful to be named as a 2024 finalist in the EIT Health Catapult Competition. From 100s of companies considered ➡️ to 30 semi-finalists ➡️ to
Our recently published clinical validation study marks what we hope is a landmark moment for breast cancer patients and physicians all around the world. The
London, UK – 24 January 2024. A clinical validation study for Digistain’s novel, rapid and cost-effective alternative to transcriptomic risk profiling in order to efficaciously
We are the finalists of Health Tech Challengers 2023. Join us at the event
We take pride in our involvement with SpinOff Bulgaria, a program dedicated to nurturing innovation and promoting entrepreneurial spirit.
Delighted to have been selected by EIT Health as a semi-finalist. Wonderful to be recognised for our groundbreaking work in advancing breast cancer biomarker analytics.
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.
Digistain LIMITED, Unit 101, Interchange Business Park, Howard Way, Newport Pagnell, MK16 9PY, United Kingdom
From the UK: 020 3951 9812
Outside the UK: +44 20 3951 9812
e-mail: contact@digistain.co.uk
Copyright © 2010 - 2024. Digistain ® and the Digistain Logo are registered trademarks of Digistain LIMITED. All Rights Reserved.
